Literature DB >> 19841645

The gut feeling of Treg cells: IL-10 is the silver lining during colitis.

Derya Unutmaz, Bali Pulendran.   

Abstract

Regulatory T cells that express the transcription factor Foxp3 are pivotal in suppressing autoimmune responses. A report in this issue describes a key role for interleukin 10 produced by lamina propria macrophages in maintaining Foxp3 expression during inflammatory responses in the intestine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19841645     DOI: 10.1038/ni1109-1141

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  11 in total

1.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

Review 2.  Regulatory T cells and immune tolerance.

Authors:  Shimon Sakaguchi; Tomoyuki Yamaguchi; Takashi Nomura; Masahiro Ono
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

Review 3.  Role of cytokines in the pathogenesis of inflammatory bowel disease.

Authors:  K A Papadakis; S R Targan
Journal:  Annu Rev Med       Date:  2000       Impact factor: 13.739

4.  Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.

Authors:  Timothy L Denning; Yi-chong Wang; Seema R Patel; Ifor R Williams; Bali Pulendran
Journal:  Nat Immunol       Date:  2007-09-16       Impact factor: 25.606

5.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

6.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis.

Authors:  Masako Murai; Olga Turovskaya; Gisen Kim; Rajat Madan; Christopher L Karp; Hilde Cheroutre; Mitchell Kronenberg
Journal:  Nat Immunol       Date:  2009-09-27       Impact factor: 25.606

Review 7.  Interleukin-10-based therapy for inflammatory bowel disease.

Authors:  Henri Braat; Maikel P Peppelenbosch; Daan W Hommes
Journal:  Expert Opin Biol Ther       Date:  2003-08       Impact factor: 4.388

Review 8.  Plasticity of CD4(+) FoxP3(+) T cells.

Authors:  Xuyu Zhou; Samantha Bailey-Bucktrout; Lukas T Jeker; Jeffrey A Bluestone
Journal:  Curr Opin Immunol       Date:  2009-06-06       Impact factor: 7.486

9.  TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.

Authors:  Julien C Marie; John J Letterio; Marc Gavin; Alexander Y Rudensky
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606

View more
  17 in total

Review 1.  M cell-targeted mucosal vaccine strategies.

Authors:  M Yamamoto; D W Pascual; H Kiyono
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

2.  A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation.

Authors:  Rose A Whelan; Sebastian Rausch; Friederike Ebner; Dorothee Günzel; Jan F Richter; Nina A Hering; Jörg-Dieter Schulzke; Anja A Kühl; Ahmed Keles; Pawel Janczyk; Karsten Nöckler; Lothar H Wieler; Susanne Hartmann
Journal:  Mol Ther       Date:  2014-07-02       Impact factor: 11.454

Review 3.  Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.

Authors:  Sergio Rutella; Franco Locatelli
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

Review 4.  Animal models of inflammatory bowel disease: a review.

Authors:  Nidhi Goyal; Ajay Rana; Abhilasha Ahlawat; Krishna Reddy V Bijjem; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-06-07       Impact factor: 4.473

5.  Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.

Authors:  Jun Yao; Cheng Wei; Jian-Yao Wang; Ru Zhang; Ying-Xue Li; Li-Sheng Wang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

6.  Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.

Authors:  Qingdong Guan; Yanbing Ma; China-Li Hillman; Gefei Qing; Allan G Ma; Carolyn R Weiss; Gang Zhou; Aiping Bai; Richard J Warrington; Charles N Bernstein; Zhikang Peng
Journal:  Mol Med       Date:  2011-03-11       Impact factor: 6.354

7.  Droplet-based microfluidic platforms for single T cell secretion analysis of IL-10 cytokine.

Authors:  Tania Konry; Margarita Dominguez-Villar; Clare Baecher-Allan; David A Hafler; Martin L Yarmush
Journal:  Biosens Bioelectron       Date:  2010-09-15       Impact factor: 10.618

8.  Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T/T helper 17 cell balance in the treatment of colitis in mice.

Authors:  Zhenglei Xu; Cheng Wei; R U Zhang; Jun Yao; Dinguo Zhang; Lisheng Wang
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

9.  Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers.

Authors:  Ian Teo; Steve M Toms; Benoit Marteyn; Teresa S Barata; Peter Simpson; Karen A Johnston; Pamela Schnupf; Andrea Puhar; Tracey Bell; Chris Tang; Mire Zloh; Steve Matthews; Phillip M Rendle; Philippe J Sansonetti; Sunil Shaunak
Journal:  EMBO Mol Med       Date:  2012-08-06       Impact factor: 12.137

10.  Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota.

Authors:  Lingjun Tong; Haining Hao; Zhe Zhang; Youyou Lv; Xi Liang; Qiqi Liu; Tongjie Liu; Pimin Gong; Lanwei Zhang; Fangfang Cao; Giorgia Pastorin; Chuen Neng Lee; Xiaoyuan Chen; Jiong-Wei Wang; Huaxi Yi
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.